- Home
- RPRX vs ULTA Comparison
RPRX vs ULTA Comparison
Compare RPRX & ULTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | ULTA |
|---|---|---|
| Founded | 1996 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4B | 23.2B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RPRX | ULTA |
|---|---|---|
| Price | $70.15 | $659.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 28 |
| Target Price | $72.00 | ★ $635.84 |
| AVG Volume (30 Days) | ★ 3.2M | 449.0K |
| Earning Date | 11-04-2026 | 12-03-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 1.18 |
| EPS | 1.03 | ★ 14.31 |
| Revenue | $2,378,193,000.00 | ★ $12,392,820,000.00 |
| Revenue This Year | $49.27 | $7.13 |
| Revenue Next Year | $9.11 | $5.16 |
| P/E Ratio | $67.27 | ★ $46.56 |
| Revenue Growth | 5.06 | ★ 9.71 |
| 52 Week Low | $37.31 | $443.60 |
| 52 Week High | $69.77 | $714.97 |
Technical Indicators
Market Signals| Indicator | RPRX | ULTA |
|---|---|---|
| Relative Strength Index (RSI) | 77.70 | 65.38 |
| Support Level | $55.48 | $502.10 |
| Resistance Level | N/A | $708.75 |
| Average True Range (ATR) | 1.57 | 18.47 |
| MACD | 0.35 | 0.63 |
| Stochastic Oscillator | 95.66 | 75.77 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ULTA Ulta Beauty Inc.
Ulta Beauty is the largest specialized beauty retailer in the US with more than 1,500 stores and e-commerce. The firm offers cosmetics (38% of 2025 sales), fragrances (13%), skin care (24%), and hair care products (19%). It also has salon services, including hair, makeup, skin, and brow, that account for 4% of its revenue and drive customer traffic. Outside of the US, Ulta operates premium beauty retailer Space NK (86 stores at year-end 2025 in the UK and Ireland), has franchised stores in Mexico, and a joint venture in the Middle East. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.